Le Généraliste (Abonnement) Seconde vie pour la sertraline pour lutter contre la méningite cryptococcique en Afrique. David Meya, un chercheur basé en Ouganda espère, avec le soutien du Canada, donner une seconde vie à un antidépresseur très répandu sur le marché depuis 1991: ...
RedOrbit Patient outcomes for over 300,000 patients who were prescribed a similar antidepressant, sertraline , were also examined. Sertraline does not have an FDA warning. The study found no elevated risks of ventricular arrhythmia or death related to higher ... and more »
Science Daily (press release) The study also examined patient outcomes for more than 300,000 patients who were prescribed a similar antidepressant, sertraline , which d...
Maxisciences C'est avec le soutien du Canada que des chercheurs de l'Institut des maladies infectieuses de l'université Makerere, en Ouganda, espèrent pouvoir détourner ...
AFP Sertraline , better known as Zoloft or Lustral, was first introduced by pharmaceutical giant Pfizer in 1991. It has since become the second-most prescribed antidepressant in the United States. But recent lab work at the University of Utah found that the ...
New Vision Furthermore, since drug patents for sertraline are now expired, it would be possible for generic drug makers to produce and sell it more cheaply. The Canadian government is helping Meya's team with $100,000 (US$99,364) in seed funding through a ...
University of Michigan Health System News (press release) The study also examined patient outcomes for more than 300,000 patients who were prescribed a similar antidepressant, sertraline , which does not have an FDA warning. Results indicated no elevated risks of ventricular arrhythmia or death related to ... and more »
FRANCE 24 Canada is funding testing in Uganda of a popular off-patent antidepressant drug, Sertraline , to fight a fungal brain disease that claims more than half a million lives in sub-Saharan Africa every year. AFP - Canada is funding testing in Uganda of a ... and more »
